Tirzepatide Shows Improvements in MASH Resolution, Fibrosis

Encouraging phase 2 results of tirzepatide in the resolution of MASH and improvement in fibrosis support further investigation into the GIP–GLP-1 receptor agonist for liver disease.
Medscape Medical News